Clinical Trials in Arizona

Showing 12421-12440 of 16,770 trials

ESSENTIAL Trial™ Sham Cross-over

NCT02279420

This is a multicenter, un-blinded, open label, pivotal supplemental study to G130163 intended to evaluate the safety and efficacy of treating previous sham subjects in the Essential pivotal trial (IDE#G130163) with the active treatment (the placement of g-Cath EZ suture anchors along with diet and exercise). Compliant sham subjects (those who attended all primary IDE follow-up visits AND who continue to meet eligibility criteria as described in this protocol) will be offered this active treatment after their 12 month unblinding visit in the Essential pivotal trial.

Obesity

USGI Medical73 participantsStarted Jan 2015

Scottsdale, Arizona, United States • Miami, Florida, United States • Dalton, Georgia, United States +8 more locations

COMPLETEDPhase 231 miles

Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

NCT02098473

The purpose of this study is to determine the effective dose(s) of RPC4046 in the treatment of Eosinophilic Esophagitis (EoE). This trial consists of two phases: 16 weeks of double-blind treatment and 52 weeks of open-label extension.

Eosinophilic Esophagitis

Celgene100 participantsStarted Aug 2014

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Oceanside, California, United States +27 more locations

ESSENTIAL Trial™ Sham Cross-over

Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

Find Trials by Condition in Arizona

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

Parent Engagement Package: Initial Testing of Strategies to Increase Participation in Parenting Interventions

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Ovarian Cancer Vaccine for Patients in Remission

Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects

The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

Dose-Escalation Study of GSK2126458

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC